Skip to main content
. 2022 Oct 4;45(5):150–157. doi: 10.18773/austprescr.2022.054

Table 2. Adverse effects of osteoporosis drugs.

Drug Common adverse events Notable rare adverse events
Oral bisphosphonate Hypocalcaemia
Upper gastrointestinal effects (gastro-oesophageal reflux, erosive oesophagitis)
Osteonecrosis of the jaw*
Atypical femoral fractures †
Intravenous bisphosphonates Hypocalcaemia
Flu-like illness following infusion
Osteonecrosis of the jaw*
Atypical femoral fractures †
Denosumab Hypocalcaemia
Injection-site reactions
Atraumatic vertebral fractures following discontinuatio
Osteonecrosis of the jaw*
Atypical femoral fractures †
Raloxifene Hot flushes
Venous thromboembolism
Stroke
Teriparatide Hypercalcaemia
Injection-site reactions
Theoretical risk of osteosarcoma
Romosozumab Injection-site reactions Possible increased risk of major adverse cardiovascular events (myocardial infarction, stroke)
Osteonecrosis of the jaw* (few case reports)
Atypical femoral fractures † (few case reports)

* Risk factors include dental extractions, implants, poorly fitting dentures, pre-existing dental disease, glucocorticoid use and smoking.

† Risk factors include rheumatoid arthritis, increased femoral bowing, thicker lateral cortices at the femoral shaft and Asian ethnicity.